Patterns of Failure as a Function of Clinical Target Volumes in Patients With GBM Treated With Radiation Therapy (RT), Temozolomide, and Bevacizumab

被引：0
|
作者：
Lewis, S. [1 ]
Vredenburgh, J. [1 ]
Desjardins, A. [1 ]
Peters, K. [1 ]
Green, S. [1 ]
Hood, R. [1 ]
Yang, Y. [1 ]
Sampson, J. [1 ]
Wang, Z. [1 ]
Kirkpatrick, J. P. [1 ]
机构：
[1] Duke Univ, Durham, NC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.694
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S266 / S267
页数：2
相关论文
共 50 条
  • [1] NEWLY DIAGNOSED GLIOBLASTOMA TREATED WITH GLIADEL® FOLLOWED BY RADIATION THERAPY (RT), TEMOZOLOMIDE AND BEVACIZUMAB, AND POST-RT BEVACIZUMAB AND TEMOZOLOMIDE: A PHASE II STUDY
    Desjardins, Annick
    Peters, Katherine B.
    Herndon, James E., II
    Bailey, Leigh Ann
    Alderson, Lloyd M.
    Ranjan, Tulika
    Sampson, John H.
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 104 - 104
  • [2] BEVACIZUMAB GIVEN WITH TEMOZOLOMIDE AND RADIATION THERAPY (RT) IN NEWLY DIAGNOSED PATIENTS WITH GLIOBLASTOMA MULTIFORME (GBM) REDUCES THE CHANCE OF EARLY RADIOLOGIC PROGRESSION
    Alderson, Lloyd M.
    Desjardins, Annick
    Ranjan, Tulika
    Peters, Katherine B.
    Friedman, Henry S.
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 81 - 81
  • [3] Patterns of Failure in Patients With Glioblastoma Treated With Surgery and Intensity Modulated Radiation Therapy and Temozolomide
    Rodriguez-Ruiz, M.
    San Miguel, I.
    Moreno-Jimenez, M.
    Espinos, J.
    Arevalo, E.
    Dominguez, P.
    Tejada, S.
    Arbizu, J.
    Idoate, M. A.
    Aristu, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S273 - S273
  • [4] PHASE II TRIAL OF BEVACIZUMAB, RADIATION THERAPY (RT) AND TEMOZOLOMIDE FOLLOWED BY BEVACIZUMAB AND TEMOZOLOMIDE WITH CONTINUATION OF BEVACIZUMAB BEYOND PROGRESSION
    Ghiaseddin, Ashley
    Dunn-Pirio, Anastasie
    Peters, Katherine
    Vlahovic, Gordana
    Herndon, James, II
    Threatt, Stevie
    Sampson, John
    Friedman, Allan
    Friedman, Henry
    Desjardins, Annick
    NEURO-ONCOLOGY, 2014, 16
  • [5] Bevacizumab, temozolomide, and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly-diagnosed glioblastoma multiforme (GBM).
    Vredenburgh, J. J.
    Desjardins, A.
    Reardon, D. A.
    Peters, K.
    Kirkpatrick, J.
    Coan, A. D.
    Bailey, L.
    Janney, D.
    Lu, C.
    Friedman, H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] The addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and oral topotecan for newly diagnosed glioblastoma multiforme (GBM).
    Friedman, Henry S.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Kirkpatrick, John
    Herndon, James Emmett
    Coan, April D.
    Bailey, Leighann
    Sampson, John Howard
    Friedman, Allan H.
    Vredenburgh, James J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Phase II trial for patients with newly diagnosed glioblastoma (GBM) treated with carmustine wafers followed by concurrent radiation therapy (RT), temozolomide (TMZ), and bevacizumab (BV), then followed by TMZ and BV post-RT.
    Ranjan, Tulika
    Peters, Katherine B.
    Vlahovic, Gordana
    Alderson, Lloyd M.
    Herndon, James Emmett
    McSherry, Frances
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Bigner, Darell D.
    Friedman, Henry S.
    Vredenburgh, James J.
    Desjardins, Annick
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] PENETRATION OF RADIOLABELED TEMOZOLOMIDE CORRELATES WITH CONTRAST ENHANCEMENT IN PATIENTS WITH RECURRENT GBM TREATED WITH BEVACIZUMAB
    Yen, Yi-Fen
    Da, Xiao
    Catana, Ciprian
    Ou, Yangming
    Hooker, Jacob
    Kalpathy-Cramer, Jayashree
    Rosen, Bruce
    Batchelor, Tracy
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2016, 18 : 133 - 133
  • [9] PHASE II TRIAL OF UPFRONT BEVACIZUMAB WITH TEMOZOLOMIDE AND RADIATION THERAPY FOLLOWED BY BEVACIZUMAB, TEMOZOLOMIDE AND ORAL TOPOTECAN FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM)
    Ranjan, Tulika
    Desjardins, Annick
    Peters, Katherine B.
    Alderson, Lloyd
    Kirkpatrick, John
    Herndon, James, II
    Bailey, Leighann
    Sampson, John
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2012, 14 : 79 - 79
  • [10] Concurrent bevacizumab and temozolomide alter the patterns of failure in radiation treatment of glioblastoma multiforme
    Shields, Lisa B. E.
    Kadner, Robert
    Vitaz, Todd W.
    Spalding, Aaron C.
    RADIATION ONCOLOGY, 2013, 8
12345